Home

LARRY N FEINBERG

CIK 926475 · last filed 2021-02-05

LARRY N FEINBERG is a corporate insider who has filed 62 SEC Form 4 insider transactions across 7 companies since 2012. The most recent filing shows the insider sold $224.8K of MOTS on Feb 5, 2021. Across all open-market trades the lifetime net is +$125.3M, making them a net buyer over the disclosed history. 42 SEC filings were submitted jointly with ORACLE PARTNERS LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

7

Total Filings

62

Lifetime Open-Market Net

$125.27M

Filer Profile

Reported Address
C/O ORACLE PARTNERS L P
200 GREENWICH AVENUE
GREENWICH, CT 06830
State of Incorporation
NY
Related Filers
ORACLE PARTNERS LP — 42 joint filings, latest 2021-02-05
Oracle Associates LLC — 37 joint filings, latest 2017-12-26
Oracle Ten Fund Master, LP — 8 joint filings, latest 2017-08-31
ORACLE INSTITUTIONAL PARTNERS L P — 7 joint filings, latest 2017-08-31
AGENUS INC — 5 joint filings, latest 2022-02-11
BIOGEN INC. — 4 joint filings, latest 1999-02-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Motus GI Holdings, Inc. (MOTS) Delisted 10%+ Owner 0 $0.00 $0 $5.97M 2 2021-02-05
SOLENO THERAPEUTICS INC (SLNO) Delisted 10%+ Owner 43,667 $53.01 $2.31M -$1.36M 2 2020-09-30
Aspira Women's Health Inc. (VRML) Delisted 10%+ Owner 2,595,980 — — $8.40M 3 2020-06-10
BIOLASE, INC (BIOL) Delisted 10%+ Owner 5 $0.02 $0 $39.31M 12 2019-10-31
SOLENO THERAPEUTICS INC (SLNOW) Delisted 10%+ Owner 2,615,481 — — $2.50M 3 2019-03-18
Accelerate Diagnostics, Inc (AXDX) Delisted 10%+ Owner 65,409 $0.03 $2.2K $1.27M 21 2016-02-09
HANSEN MEDICAL INC (HNSN) Delisted 10%+ Owner 3,113,291 — — $69.18M 18 2015-05-14

Recent Filings

62 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-02-05 Motus GI Holdings, Inc. (MOTS) Delisted Sell (S) −118,230 -$224.8K EDGAR
2020-09-30 SOLENO THERAPEUTICS INC (SLNO) Delisted — — $0 EDGAR
2020-06-10 Aspira Women's Health Inc. (VRML) Delisted Exer (X) +926,596 $1.67M EDGAR
2020-06-09 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −400,486 -$1.36M EDGAR
2019-10-31 BIOLASE, INC (BIOL) Delisted Buy (P) +34,782 $2.00M EDGAR
2019-07-01 Motus GI Holdings, Inc. (MOTS) Delisted Buy (P) +2,063,332 $6.19M EDGAR
2019-03-18 SOLENO THERAPEUTICS INC (SLNOW) Delisted Buy (P) +260,726 $318.8K EDGAR
2018-12-21 SOLENO THERAPEUTICS INC (SLNOW) Delisted Buy (P) +1,245,135 $2.00M EDGAR
2018-05-16 SOLENO THERAPEUTICS INC (SLNOW) Delisted Buy (P) +100,000 $179.6K EDGAR
2017-12-06 BIOLASE, INC (BIOL) Delisted Buy (P) +50,182,460 $21.76M EDGAR
Showing 1–10 of 62
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.